Study finds multidrug resistance in HIV-positive youths

04/19/2011 | HealthDay News · Guardian (London), The

A European study in The Lancet found that about one in eight HIV-positive patients younger than 16 becomes resistant to three main antiviral classes, including protease inhibitors, within five years of starting them. Researchers learned that those who begin therapy at an older age have a greater risk of triple-class virological failure. The higher rate of multidrug resistance in young patients might be associated with lower medication adherence, an expert said.

View Full Article in:

HealthDay News · Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC